2023-2029 Global Lung Disease Therapeutic Drug Industry Research & Trends Analysis Report
According to Latest Research, the global market for Lung Disease Therapeutic Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Lung Disease Therapeutic Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Lung Disease Therapeutic Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Corticosteroids segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacies has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Lung Disease Therapeutic Drug include GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals and Cipla, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Lung Disease Therapeutic Drug. Report Highlights:
(1) Global Lung Disease Therapeutic Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Lung Disease Therapeutic Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Lung Disease Therapeutic Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Lung Disease Therapeutic Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Lung Disease Therapeutic Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Lung Disease Therapeutic Drug, capacity, production and trends.
(7) Lung Disease Therapeutic Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Corticosteroids
Bronchodilator Medications
Mucolytics
Antimicrobial Medications
Others
Market segment by application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
1 Market Overview
1.1 Lung Disease Therapeutic Drug Definition
1.2 Global Lung Disease Therapeutic Drug Market Size and Forecast
1.2.1 By Revenue, Global Lung Disease Therapeutic Drug Market Size, 2018-2029
1.2.2 By Sales Volume, Global Lung Disease Therapeutic Drug Market Size, 2018-2029
1.2.3 Global Lung Disease Therapeutic Drug Price Trend, 2018-2029
1.3 China Lung Disease Therapeutic Drug Market Size and Forecast
1.3.1 By Revenue, China Lung Disease Therapeutic Drug Market Size, 2018-2029
1.3.2 By Sales Volume, China Lung Disease Therapeutic Drug Market Size, 2018-2029
1.3.3 China Lung Disease Therapeutic Drug Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Lung Disease Therapeutic Drug Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Lung Disease Therapeutic Drug Share in Global Market, 2018-2029
1.4.3 Lung Disease Therapeutic Drug Market Size: China VS Global, 2018-2029
1.5 Lung Disease Therapeutic Drug Market Dynamics
1.5.1 Lung Disease Therapeutic Drug Market Drivers
1.5.2 Lung Disease Therapeutic Drug Market Restraints
1.5.3 Lung Disease Therapeutic Drug Industry Trends
1.5.4 Lung Disease Therapeutic Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Lung Disease Therapeutic Drug Revenue by Company, 2018-2023
2.2 Global Lung Disease Therapeutic Drug Sales Volume by Company, 2018-2023
2.3 Global Lung Disease Therapeutic Drug Price by Company, 2018-2023
2.4 Global Lung Disease Therapeutic Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Lung Disease Therapeutic Drug Concentration Ratio
2.6 Global Lung Disease Therapeutic Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Lung Disease Therapeutic Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Lung Disease Therapeutic Drug Revenue by Company, 2018-2023
3.2 China Lung Disease Therapeutic Drug Sales Volume by Company, 2018-2023
3.3 China Lung Disease Therapeutic Drug Lung Disease Therapeutic Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Lung Disease Therapeutic Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Lung Disease Therapeutic Drug Domestic VS Export
3.6 China Market, Lung Disease Therapeutic Drug Import & Export
3.6.1 China Market, Lung Disease Therapeutic Drug Import & Export, 2018-2029
3.6.2 China Lung Disease Therapeutic Drug Import & Export Trends
3.6.3 Main Sources of China Lung Disease Therapeutic Drug Import
3.6.4 Export Destination of China Lung Disease Therapeutic Drug
4 Lung Disease Therapeutic Drug Production by Region
4.1 Global Lung Disease Therapeutic Drug Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Lung Disease Therapeutic Drug Manufacturers
4.3 Global Major Manufacturers, Lung Disease Therapeutic Drug Capacity Expansion and Future Plans
4.4 Global Lung Disease Therapeutic Drug Capacity by Region
4.5 Global Lung Disease Therapeutic Drug Production by Region
4.5.1 Global Lung Disease Therapeutic Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Lung Disease Therapeutic Drug Production by Region, 2018-2023
4.5.3 Global Lung Disease Therapeutic Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lung Disease Therapeutic Drug Industry Chain
5.2 Lung Disease Therapeutic Drug Upstream Analysis
5.2.1 Lung Disease Therapeutic Drug Core Raw Materials
5.2.2 Main Manufacturers of Lung Disease Therapeutic Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lung Disease Therapeutic Drug Production Mode
5.6 Lung Disease Therapeutic Drug Procurement Model
5.7 Lung Disease Therapeutic Drug Industry Sales Model and Sales Channels
5.7.1 Lung Disease Therapeutic Drug Sales Model
5.7.2 Lung Disease Therapeutic Drug Typical Distributors
6 Sights by Type
6.1 Lung Disease Therapeutic Drug Classification
6.1.1 Corticosteroids
6.1.2 Bronchodilator Medications
6.1.3 Mucolytics
6.1.4 Antimicrobial Medications
6.1.5 Others
6.2 By Type, Global Lung Disease Therapeutic Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lung Disease Therapeutic Drug Revenue, 2018-2029
6.4 By Type, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029
6.5 By Type, Global Lung Disease Therapeutic Drug Price, 2018-2029
7 Sights by Application
7.1 Lung Disease Therapeutic Drug Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Lung Disease Therapeutic Drug Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lung Disease Therapeutic Drug Revenue, 2018-2029
7.4 By Application, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029
7.5 By Application, Global Lung Disease Therapeutic Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lung Disease Therapeutic Drug Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Lung Disease Therapeutic Drug Revenue, 2018-2029
8.3 By Region, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Lung Disease Therapeutic Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lung Disease Therapeutic Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lung Disease Therapeutic Drug Market Size Market Share
8.7 South America
8.7.1 South America Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lung Disease Therapeutic Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lung Disease Therapeutic Drug Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Lung Disease Therapeutic Drug Revenue, 2018-2029
9.3 By Country, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Lung Disease Therapeutic Drug Market Size, 2018-2029
9.4.2 By Company, U.S. Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lung Disease Therapeutic Drug Market Size, 2018-2029
9.5.2 By Company, Europe Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Lung Disease Therapeutic Drug Market Size, 2018-2029
9.6.2 By Company, China Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.6.3 By Type, China Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lung Disease Therapeutic Drug Market Size, 2018-2029
9.7.2 By Company, Japan Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lung Disease Therapeutic Drug Market Size, 2018-2029
9.8.2 By Company, South Korea Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lung Disease Therapeutic Drug Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Lung Disease Therapeutic Drug Market Size, 2018-2029
9.10.2 By Company, India Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.10.3 By Type, India Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Lung Disease Therapeutic Drug Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Lung Disease Therapeutic Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Lung Disease Therapeutic Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 GSK
10.1.1 GSK Company Information, Head Office, Market Area and Industry Position
10.1.2 GSK Lung Disease Therapeutic Drug Models, Specifications and Application
10.1.3 GSK Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 GSK Company Profile and Main Business
10.1.5 GSK Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.2.2 AstraZeneca Lung Disease Therapeutic Drug Models, Specifications and Application
10.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 AstraZeneca Company Profile and Main Business
10.2.5 AstraZeneca Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
10.3.2 Boehringer Ingelheim Lung Disease Therapeutic Drug Models, Specifications and Application
10.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Boehringer Ingelheim Company Profile and Main Business
10.3.5 Boehringer Ingelheim Recent Developments
10.4 Novartis
10.4.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.4.2 Novartis Lung Disease Therapeutic Drug Models, Specifications and Application
10.4.3 Novartis Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Novartis Company Profile and Main Business
10.4.5 Novartis Recent Developments
10.5 Mylan
10.5.1 Mylan Company Information, Head Office, Market Area and Industry Position
10.5.2 Mylan Lung Disease Therapeutic Drug Models, Specifications and Application
10.5.3 Mylan Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Mylan Company Profile and Main Business
10.5.5 Mylan Recent Developments
10.6 Vertex Pharmaceuticals
10.6.1 Vertex Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.6.2 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications and Application
10.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Vertex Pharmaceuticals Company Profile and Main Business
10.6.5 Vertex Pharmaceuticals Recent Developments
10.7 F. Hoffman La Roche
10.7.1 F. Hoffman La Roche Company Information, Head Office, Market Area and Industry Position
10.7.2 F. Hoffman La Roche Lung Disease Therapeutic Drug Models, Specifications and Application
10.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 F. Hoffman La Roche Company Profile and Main Business
10.7.5 F. Hoffman La Roche Recent Developments
10.8 Teva Pharmaceuticals
10.8.1 Teva Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.8.2 Teva Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications and Application
10.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Teva Pharmaceuticals Company Profile and Main Business
10.8.5 Teva Pharmaceuticals Recent Developments
10.9 Cipla
10.9.1 Cipla Company Information, Head Office, Market Area and Industry Position
10.9.2 Cipla Lung Disease Therapeutic Drug Models, Specifications and Application
10.9.3 Cipla Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Cipla Company Profile and Main Business
10.9.5 Cipla Recent Developments
10.10 Fibrogen
10.10.1 Fibrogen Company Information, Head Office, Market Area and Industry Position
10.10.2 Fibrogen Lung Disease Therapeutic Drug Models, Specifications and Application
10.10.3 Fibrogen Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Fibrogen Company Profile and Main Business
10.10.5 Fibrogen Recent Developments
10.11 Liminal Biosciences
10.11.1 Liminal Biosciences Company Information, Head Office, Market Area and Industry Position
10.11.2 Liminal Biosciences Lung Disease Therapeutic Drug Models, Specifications and Application
10.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Liminal Biosciences Company Profile and Main Business
10.11.5 Liminal Biosciences Recent Developments
10.12 PharmAkea Therapeutics
10.12.1 PharmAkea Therapeutics Company Information, Head Office, Market Area and Industry Position
10.12.2 PharmAkea Therapeutics Lung Disease Therapeutic Drug Models, Specifications and Application
10.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 PharmAkea Therapeutics Company Profile and Main Business
10.12.5 PharmAkea Therapeutics Recent Developments
10.13 IQVIA
10.13.1 IQVIA Company Information, Head Office, Market Area and Industry Position
10.13.2 IQVIA Lung Disease Therapeutic Drug Models, Specifications and Application
10.13.3 IQVIA Lung Disease Therapeutic Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 IQVIA Company Profile and Main Business
10.13.5 IQVIA Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Lung Disease Therapeutic Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lung Disease Therapeutic Drug Market Restraints
Table 3. Lung Disease Therapeutic Drug Market Trends
Table 4. Lung Disease Therapeutic Drug Industry Policy
Table 5. Global Lung Disease Therapeutic Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global Lung Disease Therapeutic Drug Revenue Market Share by Company, 2018-2023
Table 7. Global Lung Disease Therapeutic Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Lung Disease Therapeutic Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global Lung Disease Therapeutic Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Lung Disease Therapeutic Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lung Disease Therapeutic Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Lung Disease Therapeutic Drug Manufacturers Product Type
Table 13. China Lung Disease Therapeutic Drug Revenue by Company, 2018-2023, US$ million
Table 14. China Lung Disease Therapeutic Drug Revenue Market Share by Company, 2018-2023
Table 15. China Lung Disease Therapeutic Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Lung Disease Therapeutic Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Lung Disease Therapeutic Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Lung Disease Therapeutic Drug Import & Export Trends
Table 19. Main Sources of China Lung Disease Therapeutic Drug Import
Table 20. Export Destination of China Lung Disease Therapeutic Drug
Table 21. Global Headquarters and Manufacturing Base of Lung Disease Therapeutic Drug Manufacturers
Table 22. Global Major Manufacturers, Lung Disease Therapeutic Drug Capacity Expansion and Future Plans
Table 23. Global Lung Disease Therapeutic Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Lung Disease Therapeutic Drug Production by Region, 2018-2023, (K Units)
Table 25. Global Lung Disease Therapeutic Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Lung Disease Therapeutic Drug Upstream (Raw Materials)
Table 27. Global Lung Disease Therapeutic Drug Typical Customers
Table 28. Lung Disease Therapeutic Drug Typical Distributors
Table 29. By Type, Global Lung Disease Therapeutic Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Lung Disease Therapeutic Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Lung Disease Therapeutic Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Lung Disease Therapeutic Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Lung Disease Therapeutic Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Lung Disease Therapeutic Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Lung Disease Therapeutic Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Lung Disease Therapeutic Drug Sales Volume Market Share, 2018-2029
Table 39. GSK Company Information, Head Office, Market Area and Industry Position
Table 40. GSK Lung Disease Therapeutic Drug Models, Specifications and Application
Table 41. GSK Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. GSK Company Profile and Main Business
Table 43. GSK Recent Developments
Table 44. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 45. AstraZeneca Lung Disease Therapeutic Drug Models, Specifications and Application
Table 46. AstraZeneca Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AstraZeneca Company Profile and Main Business
Table 48. AstraZeneca Recent Developments
Table 49. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 50. Boehringer Ingelheim Lung Disease Therapeutic Drug Models, Specifications and Application
Table 51. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Boehringer Ingelheim Company Profile and Main Business
Table 53. Boehringer Ingelheim Recent Developments
Table 54. Novartis Company Information, Head Office, Market Area and Industry Position
Table 55. Novartis Lung Disease Therapeutic Drug Models, Specifications and Application
Table 56. Novartis Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Novartis Company Profile and Main Business
Table 58. Novartis Recent Developments
Table 59. Mylan Company Information, Head Office, Market Area and Industry Position
Table 60. Mylan Lung Disease Therapeutic Drug Models, Specifications and Application
Table 61. Mylan Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Mylan Company Profile and Main Business
Table 63. Mylan Recent Developments
Table 64. Vertex Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 65. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications and Application
Table 66. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Vertex Pharmaceuticals Company Profile and Main Business
Table 68. Vertex Pharmaceuticals Recent Developments
Table 69. F. Hoffman La Roche Company Information, Head Office, Market Area and Industry Position
Table 70. F. Hoffman La Roche Lung Disease Therapeutic Drug Models, Specifications and Application
Table 71. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. F. Hoffman La Roche Company Profile and Main Business
Table 73. F. Hoffman La Roche Recent Developments
Table 74. Teva Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 75. Teva Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications and Application
Table 76. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Teva Pharmaceuticals Company Profile and Main Business
Table 78. Teva Pharmaceuticals Recent Developments
Table 79. Cipla Company Information, Head Office, Market Area and Industry Position
Table 80. Cipla Lung Disease Therapeutic Drug Models, Specifications and Application
Table 81. Cipla Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Cipla Company Profile and Main Business
Table 83. Cipla Recent Developments
Table 84. Fibrogen Company Information, Head Office, Market Area and Industry Position
Table 85. Fibrogen Lung Disease Therapeutic Drug Models, Specifications and Application
Table 86. Fibrogen Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Fibrogen Company Profile and Main Business
Table 88. Fibrogen Recent Developments
Table 89. Liminal Biosciences Company Information, Head Office, Market Area and Industry Position
Table 90. Liminal Biosciences Lung Disease Therapeutic Drug Models, Specifications and Application
Table 91. Liminal Biosciences Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Liminal Biosciences Company Profile and Main Business
Table 93. Liminal Biosciences Recent Developments
Table 94. PharmAkea Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 95. PharmAkea Therapeutics Lung Disease Therapeutic Drug Models, Specifications and Application
Table 96. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. PharmAkea Therapeutics Company Profile and Main Business
Table 98. PharmAkea Therapeutics Recent Developments
Table 99. IQVIA Company Information, Head Office, Market Area and Industry Position
Table 100. IQVIA Lung Disease Therapeutic Drug Models, Specifications and Application
Table 101. IQVIA Lung Disease Therapeutic Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. IQVIA Company Profile and Main Business
Table 103. IQVIA Recent Developments
List of Figure
Figure 1. Lung Disease Therapeutic Drug Picture
Figure 2. By Revenue, Global Lung Disease Therapeutic Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Lung Disease Therapeutic Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Lung Disease Therapeutic Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Lung Disease Therapeutic Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Lung Disease Therapeutic Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Lung Disease Therapeutic Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Lung Disease Therapeutic Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Lung Disease Therapeutic Drug Share of Global Market, 2018-2029
Figure 10. Global Lung Disease Therapeutic Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Lung Disease Therapeutic Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Lung Disease Therapeutic Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Lung Disease Therapeutic Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Lung Disease Therapeutic Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Lung Disease Therapeutic Drug Domestic VS Export, 2022
Figure 16. Global Lung Disease Therapeutic Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Lung Disease Therapeutic Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Lung Disease Therapeutic Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. Lung Disease Therapeutic Drug Industry Chain
Figure 20. Lung Disease Therapeutic Drug Procurement Model
Figure 21. Lung Disease Therapeutic Drug Sales Model
Figure 22. Lung Disease Therapeutic Drug Sales Channels, Direct Sales and Distribution
Figure 23. Corticosteroids
Figure 24. Bronchodilator Medications
Figure 25. Mucolytics
Figure 26. Antimicrobial Medications
Figure 27. Others
Figure 28. By Type, Global Lung Disease Therapeutic Drug Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Lung Disease Therapeutic Drug Revenue Market Share, 2018-2029
Figure 30. By Type, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Lung Disease Therapeutic Drug Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Lung Disease Therapeutic Drug Price, 2018-2029, (US$/Unit)
Figure 33. Hospital Pharmacies
Figure 34. Retail Pharmacies
Figure 35. Online Pharmacies
Figure 36. By Application, Global Lung Disease Therapeutic Drug Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Lung Disease Therapeutic Drug Revenue Market Share, 2018-2029
Figure 38. By Application, Global Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Lung Disease Therapeutic Drug Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Lung Disease Therapeutic Drug Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Lung Disease Therapeutic Drug Revenue Market Share, 2018-2029
Figure 42. By Region, Global Lung Disease Therapeutic Drug Sales Volume Market Share, 2018-2029
Figure 43. North America Lung Disease Therapeutic Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Lung Disease Therapeutic Drug Revenue Market Share, 2022
Figure 45. Europe Lung Disease Therapeutic Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Lung Disease Therapeutic Drug Revenue Market Share, 2022
Figure 47. Asia Pacific Lung Disease Therapeutic Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Lung Disease Therapeutic Drug Revenue Market Share, 2022
Figure 49. South America Lung Disease Therapeutic Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Lung Disease Therapeutic Drug Revenue Market Share, 2022
Figure 51. Middle East & Africa Lung Disease Therapeutic Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. Lung Disease Therapeutic Drug Market Share, 2022
Figure 54. By Type, U.S. Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe Lung Disease Therapeutic Drug Market Share, 2022
Figure 58. By Type, Europe Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 60. China Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China Lung Disease Therapeutic Drug Market Share, 2022
Figure 62. By Type, China Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan Lung Disease Therapeutic Drug Market Share, 2022
Figure 66. By Type, Japan Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea Lung Disease Therapeutic Drug Market Share, 2022
Figure 70. By Type, South Korea Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia Lung Disease Therapeutic Drug Market Share, 2022
Figure 74. By Type, Southeast Asia Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 76. India Lung Disease Therapeutic Drug Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India Lung Disease Therapeutic Drug Market Share, 2022
Figure 78. By Type, India Lung Disease Therapeutic Drug Sales Volume Market Share, 2022 VS 2029
Figure 79. By Appli
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|